Clinical review procedures for the Antiretroviral Pregnancy Registry
- 23 April 2004
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 13 (8) , 529-536
- https://doi.org/10.1002/pds.971
Abstract
The Antiretroviral Pregnancy Registry (APR) is an international pregnancy exposure registry designed to monitor prenatal antiretroviral medication exposures and detect any potential increase in the risk of major birth defects. The APR process imitates that of the Metropolitan Atlanta Congenital Defects Program (MACDP) modified to account for the differences in surveillance systems. The APR case definition attempts to separate prenatal and postnatal medication exposure, includes cases with multiple conditional defects only and collects cases diagnosed at later ages. Possible temporal association between defect pathogenesis and antiretroviral medication exposure includes a way to identify cases with known etiology—such as familial genetic conditions—and those with currently ambiguous pathogenesis—like hemangiomata and club feet. The APR also accounts for confounding factors like maternal alcohol use. Some defect reports automatically generate questions back to the reporter asking for more information. The APR incorporates procedures for managing and recording some of the more inconsistently reported malformations, such as microcephaly. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 10 references indexed in Scilit:
- Exposure to Antiretroviral Therapy in Utero or Early Life: the Health of Uninfected Children Born to HIV-Infected WomenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Accumulation of Mitochondrial DNA Mutations in Human Immunodeficiency Virus–Infected Patients Treated with Nucleoside-Analogue Reverse-Transcriptase InhibitorsAmerican Journal of Human Genetics, 2003
- Mitochondrial disruption and apoptosis in lymphocytes of an HIV infected patient affected by lactic acidosis after treatment with highly active antiretroviral therapyJournal of Clinical Pathology, 2003
- Mitochondrial Damage Associated With Long-Term Antiretroviral Treatment: Associated Alteration or Causal Disorder?JAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registryPharmacoepidemiology and Drug Safety, 2002
- Lack of Evidence of Mitochondrial Dysfunction in the Offspring of HIV‐Infected Women: Retrospective Review of Perinatal Exposure to Antiretroviral Drugs in the Perinatal AIDS Collaborative Transmission StudyAnnals of the New York Academy of Sciences, 2000
- Evaluation of selected characteristics of pregnancy drug registriesTeratology, 1999
- Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analoguesThe Lancet, 1999
- Predictive value of minor anomalies: II. Use in cohort studies to identify teratogensTeratology, 1987
- Predictive value of minor anomalies. I. Association with major malformationsThe Journal of Pediatrics, 1987